A December 2025 trading plan covers Todd M. Duchene's 10,000-share sale at Core Scientific (CORZ).
Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific (CORZ), sold 10,000 shares of common stock on September 28, 2026, at a weighted average price of $16.7586 per share. This transaction was conducted under a Rule 10b5-1 trading plan adopted on December 5, 2025. Following the sale, Duchene directly holds 1,187,896 shares, with an additional 700,000 shares held indirectly through a grantor retained annuity trust.
Form 4 Core Scientific Inc For: 1 October By Investing.com
This article announces the filing of Form 4 for Core Scientific Inc. on October 1. It provides a brief mention of the company and its stock symbol (CORZ), alongside general market data and other news headlines.
Total liabilities of Core Scientific Inc – HAN:7ZD
This page provides financial information for Core Scientific Inc (HAN:7ZD) listed on the Hannover Stock Exchange. It specifically focuses on the company's total liabilities, though no specific values are displayed in the provided content. The article is primarily a stub for financial data that would typically be presented in a table or chart.
Core Scientific Inc (CORZ) Stock Down 4.7% but Still Overvalued -- GF Score: 29/100
Core Scientific Inc (CORZ) stock recently dropped by 4.7% to $16.52, yet GuruFocus assesses it as 33.1% overvalued with a GF Value™ of $12.41. The company's GF Score™ is a low 29/100, reflecting weak profitability, growth, and financial strength, alongside significant net insider selling totaling $5.1 million. These factors suggest considerable risk and caution for potential investors, as the stock appears overvalued with poor underlying fundamentals.
Core Scientific chief legal officer Todd Duchene sells $183,746 in shares
Core Scientific's Chief Legal and Administrative Officer, Todd M. Duchene, sold 10,000 shares of the company's common stock on September 21, 2026, totaling $183,746. The sale was executed under a Rule 10b5-1 trading plan adopted in December 2025. This transaction comes amidst varied analyst ratings, with some upgrading the stock following a major partnership with AMD, while others initiated coverage with a neutral outlook.
Form 4 Core Scientific Inc For: 27 September By Investing.com
This article announces the filing of a Form 4 for Core Scientific Inc. on September 27. It is a brief news item from Investing.com, typical of a regulatory filing announcement. The core content is just the headline and the company's stock symbol.
Core Scientific Inc (CORZ) Stock Down 4.3% but Still Overvalued -- GF Score: 51/100
Core Scientific Inc (CORZ) shares fell 4.3% to $17.34, significantly above its GF Value™ of $12.32, indicating it is 40.7% overvalued. The stock has a GF Score™ of 51/100, suggesting average overall quality with strong growth potential but weak financial strength and valuation. Insider activity shows net selling of $5.1 million, reinforcing caution for potential investors.
What Could Core Scientific (CORZ) Gain From Hiring Jay Elms As CCO?
Core Scientific (CORZ) has appointed Jay Elms as its new Chief Commercial Officer (CCO) to bolster its focus on AI-focused computing infrastructure. Elms's background in sales and commercial leadership with hyperscale data centers aligns with Core Scientific's strategy to reallocate capacity from Bitcoin mining to high-performance computing and secure long-term AI power leases. Investors will be watching for Elms to convert contracted power into new AI and hyperscale customer agreements, moving beyond existing deals with CoreWeave and AMD.
Core Scientific Appoints Jay Elms as Chief Commercial Officer
Core Scientific, Inc. (Nasdaq: CORZ) has appointed Jay Elms as its new Chief Commercial Officer. Elms, who brings over two decades of experience in the data center industry from companies like CyrusOne and NTT Global Data Centers Americas, will be responsible for expanding customer relationships and overseeing the customer experience for the digital infrastructure leader. His appointment is expected to be instrumental in aligning Core Scientific's commercial strategy with its growth and operational capabilities in providing high-density colocation services for AI workloads.
Core Scientific: Texas Data Center Freeze Puts Its AI Growth Story To Test (NASDAQ:CORZ)
Core Scientific (CORZ) faces new permitting risks in Texas but is well-positioned with existing ERCOT-approved power and major contracts for AI/HPC workloads. Despite a high customer concentration with CoreWeave and substantial capital expenditures, the company's transition to AI is supported by significant colocation revenue. The author rates CORZ a Hold, emphasizing growth in billing megawatts and cash flow over speculative contract announcements.
Analysts’ Top Technology Picks: Palantir Technologies (PLTR), Core Scientific Inc (CORZ)
This article highlights bullish sentiments from analysts for three technology companies: Palantir Technologies (PLTR), Core Scientific Inc (CORZ), and ams-OSRAM (AUKUF). Rosenblatt Securities reiterated a Buy rating for Palantir, UBS initiated coverage with a Buy for Core Scientific, and Jefferies reiterated a Buy for ams-OSRAM, with specific price targets and analyst success rates detailed for each.
Core Scientific Initiated at Buy by UBS
UBS has initiated coverage of Core Scientific with a "Buy" rating. This indicates a positive outlook from the investment bank regarding the company's stock performance. The report suggests potential growth or undervalued assets within Core Scientific.
Core Scientific (CORZ) legal chief sold 10,000 shares under a prearranged trading plan.
Core Scientific's Chief Legal and Administrative Officer, Todd M. Duchene, sold 10,000 shares of CORZ on September 21, 2026, at a weighted average price of $18.3746 per share. This transaction was executed under a prearranged Rule 10b5-1 trading plan adopted in December 2025. Following the sale, Duchene directly holds 1,197,896 shares and indirectly holds 700,000 shares through a grantor retained annuity trust.
Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside
UBS has initiated coverage on five AI data center operators—Core Scientific, Cipher Mining, Applied Digital, TeraWulf, and Hut 8 Corp.—with "Buy" ratings, anticipating at least 30% upside. The firm's analysis is based on the equity value per megawatt generated by new lease signings and stronger tenants, with TeraWulf, Hut 8, and Applied Digital highlighted for significant growth potential driven by major leasing deals and strategic shifts. Core Scientific and Cipher Mining also show promising prospects through diversified tenant bases and leasing opportunities.
UBS Initiates Core Scientific With Buy Rating, $24 Price Target
UBS has initiated coverage of Core Scientific (CORZ) with a "Buy" rating and a price target of $24. This new rating contributes to an average analyst rating of "Buy" for Core Scientific, with a mean price target of $34.14 across all analysts. The article indicates that full details are available to subscribers of premium news services.
Wells Fargo Initiates Core Scientific at Overweight With $28 Price Target
Wells Fargo has initiated coverage on Core Scientific (CORZ) with an Overweight rating and a $28 price target. This initiation comes as the average analyst rating for Core Scientific is currently a 'buy' with a mean price target of $35.63. Access to the full report requires a premium subscription.
Wells Fargo Initiates Core Scientific at Overweight With $28 Price Target
Wells Fargo has initiated coverage on Core Scientific (CORZ) with an "Overweight" rating and set a price target of $28. This move indicates a positive outlook on the company, which specializes in designing, building, and operating large-scale data centers for high-density colocation services and digital asset mining. Core Scientific's stock was trading at $17.21 with a 16.76% year-to-date change as of the article's publication.
Core Scientific's Chief Legal Officer Sells 10,000 Shares via 10b5-1 Trading Plan
Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc./tx (NASDAQ:CORZ), sold 10,000 common shares on September 14, 2026. This transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on December 5, 2025, with an average sale price of $17.1362 per share. Following the sale, DuChene directly owns 1,207,896 shares and indirectly holds an additional 700,000 shares through a grantor retained annuity trust (GRAT).
Core Scientific Executive Todd Duchene Sells 10,000 Shares
Todd M. Duchene, Chief Legal and Administrative Officer at Core Scientific (NASDAQ:CORZ), sold 10,000 shares of common stock for $162,300 on August 31, 2026. This sale represented 0.52% of his total holdings and was executed under a Rule 10b5-1 trading plan adopted in December 2025. The company, a digital asset mining and colocation services provider, has a market capitalization of $5.4 billion and analysts anticipate significant revenue growth despite current net losses.
Core Scientific (CORZ) Could Be 53% Undervalued If Its Growth Story Holds
Core Scientific (CORZ) stock has experienced mixed performance recently, with a significant pullback despite positive year-to-date and one-year returns. Analysts suggest the stock is 53% undervalued, with a fair value target of $37.13, driven by expectations of revenue growth and future earnings. However, another perspective views the stock as expensive based on its Price/Sales ratio compared to industry peers, indicating potential overvaluation if growth expectations are not met.
Core Scientific Secures $600 Million of Senior Secured Credit Facilities
Core Scientific, Inc. (Nasdaq: CORZ) announced it has secured $600 million in senior secured credit facilities, comprising a $100 million revolving credit facility and a $500 million letter of credit facility. This financing is expected to release approximately $300 million of restricted cash, enhancing the company's capital efficiency and financial flexibility. The funds will support general corporate purposes, working capital, and project obligations for its high-density colocation services.
Core Scientific Inc (CORZ) Shares Fall 3.0% -- GF Value Says Still Overvalued
Core Scientific Inc (CORZ) shares dropped 3.0% to $17.27, yet GuruFocus's GF Value™ still identifies the stock as significantly overvalued at $11.49, indicating a 50.3% overvaluation. The company also shows an average GF Score™ of 47/100, with weaknesses in financial strength and valuation, and exhibits significant insider selling activity totaling $4.4 million over the past year. Investors are cautioned due to the stock's high valuation, unprofitability, and lack of insider confidence.
Core Scientific Inc (CORZ) Shares Fall 3.1% -- GF Value Says Still Overvalued
Core Scientific Inc (CORZ) shares dropped 3.1% to $17.81, placing it significantly above its GF Value™ estimate of $11.41, indicating it is overvalued by 56.1%. The company's GF Score™ of 47/100 points to average performance, with strong growth potential but weak financial strength and valuation. Insider selling of $4.4M over the past year further suggests a cautious outlook for the stock.
Core Scientific Slips as Investors Weigh Texas Expansion Scrutiny and Heavy Capital Spending
Core Scientific (CORZ) saw its stock decline amidst investor concerns regarding its ambitious expansion plans in Texas and the significant capital expenditure required. The company's strategy involves substantial investment in data centers and infrastructure, which is raising questions about its financial prudence and potential for overextension. This scrutiny is contributing to negative investor sentiment.
Core Scientific (CORZ) director buys 7,000 shares in open market
Core Scientific, Inc./tx (CORZ) director Eric Stanton Weiss purchased 7,000 shares of Common Stock on August 18, 2026, at a weighted average price of $19.194 per share. This open-market transaction increased his direct holdings to 259,262 CORZ shares. The purchase involved multiple trades within a price range of $18.785 to $19.595.
Core Scientific (CORZ) legal chief sells 10,000 shares
Core Scientific's Chief Legal and Administrative Officer, Todd M. Duchene, sold 10,000 shares of common stock at a weighted average price of $20.0974 per share on August 17, 2026. Additionally, 11,205 shares were disposed of to cover tax obligations from vested restricted stock units. Both transactions were executed under a pre-established Rule 10b5-1 trading plan adopted in December 2025.
Core Scientific completes Polaris acquisition to expand power
Core Scientific Inc. (CORZ) has completed its $444.3 million acquisition of Polaris DS LLC, securing 440 megawatts of gross, grid-connected power capacity and strengthening its access to electrical power. This acquisition is a key part of Core Scientific's strategy to expand its Muskogee, Oklahoma campus to approximately 1.5 gigawatts and increase its capacity for high-density colocation and AI workloads. Despite weak financial fundamentals identified by TipRanks' AI Analyst Spark, the company is progressing with significant growth plans in the digital infrastructure market.
Alan Fournier's Bold Q2 2026 Move: Exiting Core Scientific Inc for a -4.6% Portfolio Impact
Alan Fournier, founder of Pennant Capital Management, made significant portfolio adjustments in Q2 2026, as revealed in his latest 13F filing. His most notable move was the complete liquidation of his Core Scientific Inc (NASDAQ:CORZ) stake, impacting his portfolio by -4.6%. Conversely, he initiated a new position in Versigent PLC (NYSE:VGNT) and increased his holdings in Amazon.com Inc (NASDAQ:AMZN) and Flowserve Corp (NYSE:FLS).
Core Scientific Completes Acquisition of Polaris DS, Advancing Planned Muskogee Expansion to 1.5 GW of Gross Power
Core Scientific has announced the completion of its acquisition of Polaris DS LLC for approximately $444 million in cash, securing about 440 MW of gross power capacity. This acquisition advances Core Scientific's plan to expand its Muskogee campus to 1.5 GW of gross power, aiming to deliver an additional 82 MW to customers by the second half of 2027. The company emphasizes this strategic move as part of its ongoing expansion of its power portfolio to support long-term growth in high-density colocation services.
Valiant Capital discloses 5.3% Core Scientific (CORZ) position in amended 13G
Valiant Capital, along with its entities and Christopher R. Hansen, has disclosed a 5.3% beneficial ownership stake in Core Scientific (CORZ) through an amended Schedule 13G filing. This represents 16,956,009 shares of common stock, based on 321,340,441 shares outstanding as of July 23, 2026. The filers state that these securities were acquired for investment purposes and not to influence control of Core Scientific.
Core Scientific (CORZ): Jericho Capital and Josh Resnick disclose 7.2% ownership stake
Jericho Capital Asset Management L.P. and Josh Resnick have reported a joint beneficial ownership of 22,882,942 shares of Core Scientific, Inc. common stock, which represents 7.2% of the class. They share both voting and dispositive power over these shares. This disclosure was made via a SCHEDULE 13G SEC filing, indicating an investment purpose rather than an intent to control the company.
Pentwater Capital (NASDAQ: CORZ) discloses 1.34M-share Core Scientific position
Pentwater Capital Management LP and Matthew Halbower have disclosed a beneficial ownership of 1,336,594 shares of Core Scientific, Inc. common stock, representing 0.4% of the company's outstanding shares. This includes 800,000 shares issuable upon the exercise of options. All voting and dispositive authority over these shares is reported as shared, with no sole power.
Core Scientific, Inc. completed the acquisition of Polaris DS LLC from Top Access Enterprises Limited.
Core Scientific, Inc. has finalized its acquisition of Polaris DS LLC from Top Access Enterprises Limited for an aggregate purchase price of $421 million in cash, with a potential increase of $40 million. The transaction, announced on May 5, 2026, closed on August 14, 2026, and was funded using Core Scientific's existing liquidity. Legal advisors for the deal included Milbank LLP for Top Access Enterprises Limited and Cooley LLP for Core Scientific, Inc.
Form 8K Core Scientific Inc For: 14 August By Investing.com
Core Scientific Inc. (CORZ) filed a Form 8K on August 14th. This news is presented by Investing.com, indicating a regulatory update from the company. The article briefly mentions the positive stock performance of CORZ, showing a 2.58% increase.
Core Scientific (NASDAQ:CORZ) Insider Todd Duchene Sells 10,000 Shares
Core Scientific (NASDAQ:CORZ) insider Todd Duchene sold 10,000 shares of the company's stock for a total of $199,700. Following the sale, Duchene still directly owns over 1.9 million shares valued at approximately $39.3 million. Despite the sale and a quarterly loss that missed analyst estimates, Core Scientific's stock rose 5.6%, and the company holds a "Moderate Buy" consensus rating from analysts.
Jane Street group discloses 20.1M Core Scientific (CORZ) shares in 13G/A
Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Global Trading, LLC, and Jane Street Singapore Pte. Ltd., has filed an amended Schedule 13G report disclosing beneficial ownership of 20,125,585 shares of Core Scientific (CORZ) common stock as of June 30, 2026. This represents a 6.3% stake in the company. All reported shares are held with shared voting and shared dispositive power, with no shares held with sole voting or dispositive power by the group.
Core Scientific (CORZ) legal chief sells 10,000 shares under 10b5-1 plan
Core Scientific's Chief Legal and Administrative Officer, Todd M. Duchene, sold a total of 10,000 shares of company common stock on August 10, 2026, under a Rule 10b5-1 trading plan adopted in December 2025. The sales were conducted in two transactions at weighted average prices of $19.8986 and $20.6480 per share. These open-market sales are detailed in a Form 4 filing, indicating a moderate impact and negative sentiment.
Core Scientific Rises as Investors Weigh Texas Policy Update, AMD Tie-Up, and Strong Q2 Momentum
Core Scientific (CORZ) saw a 6.5% stock increase, driven by investor confidence in its AI infrastructure, a supportive Texas policy update regarding data-center growth, and strong Q2 operating results. The company also benefited from a significant infrastructure partnership with AMD announced in late July. These factors collectively bolstered the long-term AI data-center narrative for the stock.
Core Scientific Supports Governor Abbott’s Focus on Responsible Data Center Infrastructure in Texas
Core Scientific, a leader in digital infrastructure, has voiced support for Governor Greg Abbott's initiative to enhance transparency and accountability in Texas's data center development. The company emphasizes the importance of responsible growth that prioritizes grid reliability, local residents, and proper cost allocation for infrastructure needs. Core Scientific, which has operated in Texas since 2022, advocates for collaboration among stakeholders to ensure sustainable expansion while maintaining Texas's leadership in technology and energy.
Bank of America Corp DE Purchases 3,868,535 Shares of Core Scientific, Inc. $CORZ
Bank of America Corp DE significantly increased its stake in Core Scientific, Inc. (NASDAQ:CORZ) during the first quarter, acquiring an additional 3.87 million shares, bringing its total holding to 4.81 million shares valued at approximately $71.9 million. Despite Core Scientific reporting a quarterly loss of $3.32 per share, analysts maintain a "Moderate Buy" consensus rating with an average price target of $32.18, notably higher than its current market price of $21.01. Other institutional investors have also adjusted their holdings, and insider selling activity was reported, with Core Scientific's stock performance showing a one-year low of $13.14 and a one-year high of $30.46.
Analysts Offer Insights on Technology Companies: Xiaomi (OtherXIACF) and Core Scientific Inc (CORZ)
Two analysts have issued bullish sentiments on technology companies Xiaomi (XIACF) and Core Scientific Inc (CORZ). Michael Donovan from Compass Point reiterated a Buy rating on Core Scientific Inc with a $36.00 price target, and KBW also upgraded the stock to Buy with a $28.00 price target, resulting in a Strong Buy consensus for CORZ. The article highlights these positive analyst ratings, suggesting optimism in the technology sector.
Why Core Scientific (CORZ) Is Down 8.9% After Massive AMD AI Data Center Deal And $1.16 Billion Loss
Core Scientific (CORZ) shares dropped 8.9% despite announcing a significant AI infrastructure partnership with AMD for up to 2.5 gigawatts of data center capacity, alongside reporting a substantial Q2 2026 net loss of $1.16 billion. The company is pivoting from Bitcoin mining to high-performance computing to offset recurring losses and high capital needs. Investors are weighing the potential of the AMD deal and other AI contracts against the company's financial challenges and thin cash runway.
Moody National Bank Trust Division Sells 46,482 Shares of Core Scientific, Inc. $CORZ
Moody National Bank Trust Division significantly reduced its stake in Core Scientific (NASDAQ:CORZ) by 42.6% in the second quarter, selling 46,482 shares and retaining 62,660 shares valued at approximately $1.6 million. Despite this sale, analyst sentiment for Core Scientific remains generally positive, with a "Moderate Buy" consensus rating and an average price target of $32.18. The company recently reported a substantial EPS miss for the quarter, posting a loss of $3.32 per share, though revenue of $164.2 million exceeded estimates.
Kenneth Griffin and Citadel entities (CORZ) disclose 6.5% Core Scientific ownership in 13G
Kenneth Griffin and affiliated Citadel entities have disclosed a passive ownership stake in Core Scientific, Inc. (CORZ), amounting to 6.5% of outstanding shares. This Schedule 13G filing details beneficial ownership across various Citadel entities, with Mr. Griffin personally deemed to beneficially own over 20.8 million shares. The disclosure emphasizes shared voting and dispositive power among the reporting persons.
Core Scientific (CORZ) legal chief sells 10,000 shares in 10b5-1 plan
Core Scientific's Chief Legal and Administrative Officer, Todd M. Duchene, sold a total of 10,000 shares of common stock on August 3, 2026. These sales were executed in three separate open market or private transactions at weighted-average prices ranging from $20.3903 to $22.6166 per share. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025.
Core Scientific (CORZ) investor group reports 4.4% beneficial ownership
A shareholder group including Situational Awareness entities, Leopold Aschenbrenner, and Carl Shulman reported a beneficial ownership of 4.4% in Core Scientific (CORZ), equating to 14,089,395 shares as of August 4, 2026. This marks a decrease from their previous reported stake of 8.1% (25,608,473 shares) as of July 15, 2026. The ownership percentages are based on updated share counts, and all reporting persons maintain shared voting and dispositive power over the shares.
Core Scientific, Inc. (CORZ) Live Chart and Latest Price
This article provides a live chart and the latest price for Core Scientific, Inc. (CORZ), a leading infrastructure provider in the digital asset and blockchain technology sector. It details the company's market statistics, including market cap, trading volume, and opening/closing prices, while also outlining its core business activities in digital asset mining and hosting services. Core Scientific's role in supporting blockchain networks through advanced technologies and innovative solutions is highlighted.
Core Scientific Inc (CORZ) was downgraded to a Hold Rating at KBW
KBW analyst Christopher Mcgratty downgraded Core Scientific Inc (CORZ) to a Hold rating. The company's latest earnings report showed a quarterly revenue of $164.2 million and a GAAP net loss of $1.16 billion. Despite the downgrade, the general Street consensus for Core Scientific Inc is a Strong Buy with a $33.73 average price target.
Core Scientific Is Maintained at Buy by B. Riley Securities
B. Riley Securities has reiterated its "Buy" rating on Core Scientific (NASDAQ: CORZ). The firm's analyst, Lucas Pipes, also maintained a price target of $1.50 for the company.
Form 4 Core Scientific Inc For: 3 August By Investing.com
This article reports on a Form 4 filing for Core Scientific Inc. on August 3rd. It briefly mentions the stock symbol CORZ and its performance, indicating a +10.18% change. The content primarily focuses on financial market data, news headlines, and various investment tools rather than detailing the specifics of the Form 4.
